I'm LongbridgeAI, I can summarize articles.Wall Street analysts upgraded five stocks: Jefferies upgraded GM and Ford to Buy with raised price targets; Piper Sandler upgraded Rivian and Mobileye to Overweight with higher targets; BTIG upgraded Outlook Therapeutics to Buy with a $4 target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jefferies analyst Philippe Houchois upgraded General Motors Co (NYSE:GM) from Hold to Buy and raised the price target from $90 to $99. General Motors shares closed at $82.64 on Friday. See how other analysts view this stock.
- Piper Sandler analyst Alexander Potter upgrades Rivian Automotive Inc (NASDAQ:RIVN) from Neutral to Overweight and raised the price target from $18 to $20. Rivian shares closed at $15.84 on Friday. See how other analysts view this stock.
- BTIG analyst Julian Harrison upgraded Outlook Therapeutics Inc (NASDAQ:OTLK) from Neutral to Buy and announced a $4 price target. Outlook Therapeutics shares closed at $1.40 on Friday. See how other analysts view this stock.
- Jefferies analyst Philippe Houchois upgraded Ford Motor Co (NYSE:F) from Hold to Buy and boosted the price target from $14.5 to $17.5. Ford shares closed at $14.37 on Friday. See how other analysts view this stock.
- Piper Sandler analyst Alexander Potter upgraded Mobileye Global Inc (NASDAQ:MBLY) from Neutral to Overweight and raised the price target from $10 to $12. Mobileye Global shares closed at $8.05 on Friday. See how other analysts view this stock.
Considering buying GM stock? Here’s what analysts think:
Photo via Shutterstock